
GLP-1 drugs without a prescription: Brazilian study finds use in nearly 1 in 4 participants
A survey of 860 adults found that use without a prescription was more frequent among health professionals and participants without obesity, but the authors caution that the cross-sectional design does not allow them to conclude whether these people already fell outside clinical criteria when they started treatment.


